• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与非中央型肝细胞癌相比,中央型肝细胞癌的长期随访

Long-term follow-up of central hepatocellular carcinoma in comparison with non-central hepatocellular carcinoma.

作者信息

Chang Chun-Ming, Wei Chang-Kuo, Lee Cheng-Hong, Tseng Kuo-Chih, Lin Chih-Wen, Yin Wen-Yao

机构信息

Department of General Surgery, Buddhist Dalin Tzu Chi General Hsopital , Chi-Yi, Taiwan.

出版信息

Hepatogastroenterology. 2012 Mar-Apr;59(114):492-5. doi: 10.5754/hge11361.

DOI:10.5754/hge11361
PMID:21940385
Abstract

BACKGROUND/AIMS: Multiple hepatic vessels and portal vessels are distributed in the central segments of the liver (segments IV, V and VIII). Due to its anatomical complexity, in centrally-located hepatocellular carcinoma (cHCC) it is theoretically not easy to reach a wide margin, as it is in non-central hepatocellular carcinoma (ncHCC) (segments II, III, VII and VIII). We compared their outcomes to see if cHCC has an inferior result than ncHCC.

METHODOLOGY

From August 2000 to July 2008, 213 HCC patients received curative-intended resection. Sixty-nine cHCC (group A) and 64 ncHCC (group B) received trisegmentectomy (include mesohepatectomy), bi-segmentectomy, mono-segmentectomy or subsegmentectomy. The outcomes were retrospectively analyzed.

RESULTS

The in-hospital mortality was 0% and 3.12% in groups A and B, respectively (p=0.55). The morbidity was 27.5% and 28.1% in groups A and B, respectively (p=0.23). The 1- and 3-year disease-free survival were 68%, 50% and 62%, 33% in groups A and B, respectively (p=0.39). The 1- and 3-year overall survival rates were 83%, 75% and 89%, 70% in groups A and B, respectively (p=0.91). Tumor size and numbers were significant factors for disease-free and overall survival.

CONCLUSIONS

cHCC treated by partial hepatectomy and mesohepatectomy has a comparable result to ncHCC. Mesohepatectomy is needed only in some selected patients.

摘要

背景/目的:多条肝血管和门静脉分布于肝脏中央段(第IV、V和VIII段)。由于其解剖结构复杂,理论上位于肝脏中央的肝细胞癌(cHCC)与非中央肝细胞癌(ncHCC,位于第II、III、VII和VIII段)相比,难以获得较宽的手术切缘。我们比较了两者的治疗结果,以了解cHCC的治疗效果是否劣于ncHCC。

方法

2000年8月至2008年7月,213例肝癌患者接受了根治性切除手术。69例cHCC患者(A组)和64例ncHCC患者(B组)接受了三段肝切除术(包括肝中叶切除术)、二段肝切除术、一段肝切除术或亚段肝切除术。对治疗结果进行回顾性分析。

结果

A组和B组的住院死亡率分别为0%和3.12%(p = 0.55)。A组和B组的并发症发生率分别为27.5%和28.1%(p = 0.23)。A组和B组的1年和3年无病生存率分别为68%、50%和62%、33%(p = 0.39)。A组和B组的1年和3年总生存率分别为83%、75%和89%、70%(p = 0.91)。肿瘤大小和数量是影响无病生存率和总生存率的重要因素。

结论

通过肝部分切除术和肝中叶切除术治疗的cHCC与ncHCC的治疗效果相当。仅在部分特定患者中需要进行肝中叶切除术。

相似文献

1
Long-term follow-up of central hepatocellular carcinoma in comparison with non-central hepatocellular carcinoma.与非中央型肝细胞癌相比,中央型肝细胞癌的长期随访
Hepatogastroenterology. 2012 Mar-Apr;59(114):492-5. doi: 10.5754/hge11361.
2
Mesohepatectomy for centrally located large hepatocellular carcinoma: Indications, techniques, and outcomes.针对位于肝脏中央的大型肝细胞癌的肝中叶切除术:适应症、技术及结果
Surgery. 2014 Nov;156(5):1177-87. doi: 10.1016/j.surg.2014.05.012. Epub 2014 Oct 17.
3
Is hepatic resection for recurrent or persistent hepatocellular carcinoma justified?对复发性或持续性肝细胞癌进行肝切除术是否合理?
Hepatogastroenterology. 2012 Oct;59(119):2255-9. doi: 10.5754/hge10505.
4
Treatment of centrally located hepatocellular carcinoma with central hepatectomy.采用肝中叶切除术治疗肝中叶肝细胞癌
Surgery. 2003 Mar;133(3):251-6. doi: 10.1067/msy.2003.102.
5
Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection.血清和组织血管内皮生长因子可预测肝癌患者肝部分切除术后的预后。
Hepatogastroenterology. 2012 Jan-Feb;59(113):93-7. doi: 10.5754/hge10638.
6
Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience.连续改善肝细胞癌切除术的生存结果:20 年经验。
Ann Surg. 2011 Apr;253(4):745-58. doi: 10.1097/SLA.0b013e3182111195.
7
Impact of preoperative fine-needle aspiration cytologic examination on clinical outcome in patients with hepatocellular carcinoma in a tertiary referral center.术前细针穿刺细胞学检查对三级转诊中心肝细胞癌患者临床结局的影响
Arch Surg. 2004 Feb;139(2):193-200. doi: 10.1001/archsurg.139.2.193.
8
Mesohepatectomy for hepatocellular carcinoma: a study of 256 patients.肝细胞癌的肝中叶切除术:256例患者的研究
Int J Colorectal Dis. 2008 May;23(5):543-6. doi: 10.1007/s00384-007-0411-y. Epub 2008 Jan 9.
9
Evaluation of the clinical features of HCC following hepatectomy for different stages of HCC.肝癌不同分期肝切除术后肝癌临床特征的评估。
Hepatogastroenterology. 2012 Oct;59(119):2104-11. doi: 10.5754/hge12109.
10
Predictors of poor prognosis by recurrence patterns after curative hepatectomy for hepatocellular carcinoma in Child-Pugh classification A.Child-Pugh A级肝细胞癌根治性肝切除术后复发模式导致预后不良的预测因素。
Hepatogastroenterology. 2015 Jan-Feb;62(137):164-8.

引用本文的文献

1
Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study.肝细胞癌合并微血管侵犯患者的术后辅助治疗策略:一项非随机介入性临床研究。
BMC Cancer. 2020 Jul 1;20(1):614. doi: 10.1186/s12885-020-07087-7.
2
Postoperative adjuvant radiotherapy is associated with improved survival in hepatocellular carcinoma with microvascular invasion.术后辅助放疗与微血管侵犯的肝细胞癌患者生存率提高相关。
Oncotarget. 2017 Aug 23;8(45):79971-79981. doi: 10.18632/oncotarget.20402. eCollection 2017 Oct 3.
3
Outcomes of central bisectionectomy for hepatocellular carcinoma.
中央半肝切除术治疗肝细胞癌的疗效。
HPB (Oxford). 2013 Jul;15(7):529-34. doi: 10.1111/j.1477-2574.2012.00615.x. Epub 2012 Nov 21.